Page last updated: 2024-09-04

ezetimibe and Cholesterol Ester Storage Disease

ezetimibe has been researched along with Cholesterol Ester Storage Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, JC; Lopez, AM; Posey, KS; Turley, SD1
Hegele, RA; Liu, DM; Miskie, BA; Tadiboyina, VT; Wang, J1

Other Studies

2 other study(ies) available for ezetimibe and Cholesterol Ester Storage Disease

ArticleYear
Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.
    Biochemical and biophysical research communications, 2014, Jan-17, Volume: 443, Issue:3

    Topics: Animals; Azetidines; Body Weight; Cholesterol; Cholesterol Ester Storage Disease; Disease Models, Animal; Ezetimibe; Hepatomegaly; Intestinal Mucosa; Intestines; Liver; Liver Function Tests; Male; Mice; Organ Size; Rats; Sterol Esterase; Triglycerides

2014
Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease.
    Lipids in health and disease, 2005, Oct-28, Volume: 4

    Topics: Adolescent; Amino Acid Sequence; Azetidines; Base Sequence; Child; Child, Preschool; Cholesterol Ester Storage Disease; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Lipoproteins; Lovastatin; Male; Molecular Sequence Data; Sterol Esterase

2005